Skip to content Skip to navigation

20 / 20 Blog Archive

Feb 5 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Glaucoma is a common eye disease due to degeneration of the optic nerve, and eye pressure is an important risk factor. There are limited therapies since it is difficult to model glaucoma in the lab. But a collaboration between the Mahajan and Hu labs at the Byer’s Eye Institute at...
Jan 31 2020 | Posted In: 20/20 Blog
Palo Alto, CA —  In the article published in the January 2020 issue of Cell Reports, “Structural insights into the unique activation mechanisms of a non-classical calpain and its disease-causing variants,” lead author Gabriel Velez, an MD., Ph.D. student in the Mahajan Lab, reported the crystal...
Jan 13 2020 | Posted In: 20/20 Blog
Iowa City, IA — Alexander Bassuk M.D., Ph.D., division director of Pediatric Neurology at the University of Iowa's Stead Family Children’s Hospital and longtime Mahajan Lab collaborator, appeared on Good Morning America and other national media outlets to explain how a four-year-old Iowa girl lost...
Dec 20 2019 | Posted In: 20/20 Blog
Palo Alto, CA — Mahajan lab member Teja Chemudupati was chosen by his Byers Eye Institute peers as Employee of the Quarter. Teja has worked with the lab since 2018 as a Clinical Research Coordinator and has been instrumental in building and managing the ophthalmology biorepository at Stanford’s...
Dec 4 2019 | Posted In: 20/20 Blog
Palo Alto, CA — Research from the Mahajan lab was featured on the cover of Human Mutation'sDecember 2019 issue, highlighting their manuscript, “CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.” 

Pages